All In Biotech

Drug Trial Radar · NCT04444895

A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor

An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Last checked: Nov 20, 2026Latest source record: Jun 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

73

Actual

Start

Feb 5, 2021

Primary completion

May 5, 2023

Study completion May 5, 2023

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
Collaborators
Takeda Development Center Americas, Inc.
First posted
Jun 24, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the long-term safety and efficacy of repeated subcutaneous (SC) administration of lanadelumab in adolescents and adults with non-histaminergic angioedema with normal C1-inhibitor who completed study SHP643-303 (NCT04206605).

Conditions

  • Angioedema

Interventions

  • LanadelumabDrug

    Lanadelumab SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Emergent Adverse Events (TEAEs) Including Adverse Events of Special Interest (AESI) and Serious Adverse Events (SAEs) During Treatment PeriodTime frame: From Day 0 up to Day 182
  2. Number of Participants With Treatment Emergent Adverse Events (TEAEs) Including Adverse Events of Special Interest (AESI) and Serious Adverse Events (SAEs) During Follow-upTime frame: From Day 183 up to Day 196

Locations

35 sites in 10 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Alabama

    Birmingham, Alabama

  • Medical Research of Arizona

    Scottsdale, Arizona

  • UCSD Angioedema Center

    San Diego, California

  • Allergy and Asthma Clinical Research Inc

    Walnut Creek, California

  • Asthma and Allergy Associates, PC

    Colorado Springs, Colorado

  • Rush University Medical Center

    Chicago, Illinois

  • Kanarek Allergy, Asthma and Immunology

    Overland Park, Kansas

  • Institute for Asthma & Allergy, P.C.

    Chevy Chase, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University

    St Louis, Missouri

  • Bernstein Clinical Research Center, LLC

    Cincinnati, Ohio

  • Optimed Research, LTD

    Columbus, Ohio

  • Seattle Allergy & Asthma Research Institute

    Seattle, Washington

  • Ottawa Allergy Research Corporation

    Ottawa, Ontario, Canada

  • Clinique Specialisee en Allergie de la Capitale

    Québec, Quebec, Canada

  • Hôpital Saint-Antoine

    Paris, France

  • Klinikum rechts der Isar der TU

    Munich, Bavaria, Germany

  • Klinikum der Johann Wolfgang Goethe-Universitaet pt

    Frankfurt am Main, Hesse, Germany

  • Semmelweis Egyetem

    Budapest, Hungary

  • Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco)

    Milan, Italy

  • Azienda Ospedaliera Universitaria "Federico II"

    Naples, Italy

  • Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona

    Salerno, Italy

  • A.O. Ospedali riuniti Villa Sofia - Cervello,

    Palermo, Palermo Palermo, Italy

  • Hiroshima University Hospital

    Hiroshima, Hiroshima, Japan

  • Kobe University Hospital

    Kobe, Hyōgo, Japan

  • Clover Hospital

    Fujisawa-shi, Kanagawa, Japan

  • Amsterdam UMC

    Amsterdam, Netherlands

  • Universitair Medisch Centrum Groningen

    Groningen, Netherlands

  • UMC Utrecht

    Utrecht, Netherlands

  • NZOZ Homeo Medicus, Poradnia Alergologiczna

    Bialystok, Poland

  • "ALL-MED" Specjalistyczna Opieka Medyczna Filia

    Wroclaw, Poland

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Universitario Cruces

    Barakaldo, Vizcaya, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.